GALECTIN THERAPEUTICS INC. - COMMON STOCK

Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress

15 4月 2025 08:00:01 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update

31 3月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Reports Significant Reduction in New Varices with Belapectin in U.S. Patient Population from the NAVIGATE Trial

18 2月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics to Present at the 2025 MASH-TAG Conference

10 1月 2025 08:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: GALECTIN THERAPEUTICS INC. - COMMON STOCK

20 12月 2024 10:16:30 条件 NetDania Notify

Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH

20 12月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting

18 11月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update

14 11月 2024 08:00:01 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting

15 10月 2024 08:00:01 条件 Nasdaq GlobeNewswire

Galectin Therapeutics to Participate in the H.C. Wainwright MASH Conference

30 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03 9月 2024 08:30:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update

13 8月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer

01 8月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress

04 6月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update

15 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Conference

13 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis

09 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

29 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development

12 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

13 11月 2023 08:45:52 条件 Nasdaq GlobeNewswire